Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Oxford Bioscience Partners
3128
Oxford Bioscience Partners
Suggest edits
Follow us
Also headquartered in Boston
General Electric
DraftKings
Bain Capital
Sophia
Wikibon
TA Associates
Zipcar
Bolt
Battery Ventures
PillPack
Overview
News
Investments
12
Portfolio
Portfolio Tracker
Add info
Xconomy
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
the home of AI info
Amgen puts its foot down in shiny new South San Francisco hub as it reorganizes R&D ops
the home of AI info
Amgen to Cut Another 172 Jobs Following Layoff Announcement Earlier This Month
the home of AI info
Amgen chops 172 more staffers in R&D, operations and sales amid neuroscience exit, revenue ...
the home of AI info
Amgen plans to eliminate another 172 jobs
the home of AI info
Amgen cutting almost 150 jobs in Cambridge
the home of AI info
Amgen Ends Neuroscience Research, Cuts Staff in Cambridge
the home of AI info
Drugmaker Amgen cuts a quarter of its Kendall Square research staff
the home of AI info
Amgen And Neuroscience
DealStreetAsia
Amgen to pick up 20.5% stake in BeiGene to expand in China
the home of AI info
Amgen exits neuroscience research, cuts 180 US jobs
the home of AI info
Amgen Exits Neuroscience Research: The Good, Bad, And Ugly Of Biopharma
the home of AI info
Amgen joins neuroscience exodus
the home of AI info
Amgen and Neuroscience
Xconomy
,
MedCity News
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
the home of AI info
Amgen exits neuroscience R&D to focus on growth areas
the home of AI info
Amgen exits neuroscience R&D as pharma pulls back from field
the home of AI info
Amgen (AMGN) Beats on Q3 Earnings, Ends Neuroscience R&D
the home of AI info
Amgen is joining the biopharma exodus out of neurosciences R&D
BetaKit
TIAP partners with Amgen to commercialize medical research